BFS
Bradley Foster & Sargent Portfolio holdings
AUM
$6.39B
This Quarter Return
+11.01%
1 Year Return
+19.77%
3 Year Return
+71.83%
5 Year Return
+128.21%
10 Year Return
–
AUM
$4.82B
AUM Growth
+$4.82B
(+13%)
Cap. Flow
+$159M
Cap. Flow
% of AUM
3.3%
Top 10 Holdings %
Top 10 Hldgs %
30.79%
Holding
467
New
60
Increased
190
Reduced
127
Closed
20
Top Buys
| 1 |
Netflix
NFLX
|
$30.5M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$28.5M |
| 3 |
Apple
AAPL
|
$11.9M |
| 4 |
RTX Corp
RTX
|
$10.7M |
| 5 |
IQVIA
IQV
|
$9.68M |
Top Sells
| 1 |
Comcast
CMCSA
|
$26.9M |
| 2 |
Fiserv
FI
|
$13.1M |
| 3 |
B
Barrick Mining Corporation
B
|
$8.9M |
| 4 |
Bio-Techne
TECH
|
$5.11M |
| 5 |
Becton Dickinson
BDX
|
$3.49M |
Sector Composition
| 1 | Technology | 20.82% |
| 2 | Healthcare | 17.28% |
| 3 | Financials | 10.81% |
| 4 | Industrials | 9.57% |
| 5 | Consumer Discretionary | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares Russell 2000 ETF
IWM
$67B
| $5.53M | 0.11% |
24,856
+5,043
| +25% | +$1.12M |
|
127
Kinder Morgan
KMI
$60B
| $5.18M | 0.11% |
326,503
-25,250
| -7% | -$400K |
|
128
Enterprise Products Partners
EPD
$69.6B
| $5.09M | 0.11% |
231,567
-3,533
| -2% | -$77.6K |
|
129
Arthur J. Gallagher & Co
AJG
$77.6B
| $5.04M | 0.1% |
29,698
-50
| -0.2% | -$8.48K |
|
130
TE Connectivity
TEL
$61B
| $4.92M | 0.1% |
30,512
+1,205
| +4% | +$194K |
|
131
CVS Health
CVS
$92.8B
| $4.86M | 0.1% |
47,131
+3,917
| +9% | +$404K |
|
132
Cooper Companies
COO
$13.4B
| $4.78M | 0.1% |
11,407
+164
| +1% | +$68.7K |
|
133
iShares MSCI EAFE ETF
EFA
$66B
| $4.7M | 0.1% |
59,712
+30,219
| +102% | +$2.38M |
|
134
State Street
STT
$32.6B
| $4.68M | 0.1% |
50,311
| – | – |
|
135
Cigna
CI
$80.3B
| $4.64M | 0.1% |
20,192
-3,517
| -15% | -$808K |
|
136
Target
TGT
$43.6B
| $4.62M | 0.1% |
19,942
+2,704
| +16% | +$626K |
|
137
Eli Lilly
LLY
$657B
| $4.58M | 0.09% |
16,566
+625
| +4% | +$173K |
|
138
Bristol-Myers Squibb
BMY
$96B
| $4.5M | 0.09% |
72,179
+6,497
| +10% | +$405K |
|
139
Vanguard Dividend Appreciation ETF
VIG
$95.4B
| $4.48M | 0.09% |
26,071
+9,745
| +60% | +$1.67M |
|
140
iShares Core S&P 500 ETF
IVV
$662B
| $4.47M | 0.09% |
9,366
+6,838
| +270% | +$3.26M |
|
141
Fastenal
FAST
$57B
| $4.46M | 0.09% |
69,611
-2,736
| -4% | -$175K |
|
142
CME Group
CME
$96B
| $4.42M | 0.09% |
19,345
-60
| -0.3% | -$13.7K |
|
143
Colgate-Palmolive
CL
$67.9B
| $4.37M | 0.09% |
51,171
+1,799
| +4% | +$154K |
|
|
MMP
144
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $4.32M | 0.09% |
92,983
-1,285
| -1% | -$59.7K |
|
145
VanEck Gold Miners ETF
GDX
$19B
| $4.27M | 0.09% |
133,295
+11,355
| +9% | +$364K |
|
146
Crown Holdings
CCK
$11.6B
| $4.21M | 0.09% |
38,010
+15,218
| +67% | +$1.68M |
|
147
Palo Alto Networks
PANW
$127B
| $4.14M | 0.09% |
7,427
+190
| +3% | +$106K |
|
148
Novo Nordisk
NVO
$251B
| $4.04M | 0.08% |
36,092
-537
| -1% | -$60.1K |
|
149
Keysight
KEYS
$28.1B
| $3.96M | 0.08% |
19,158
-86
| -0.4% | -$17.8K |
|
150
Novartis
NVS
$245B
| $3.95M | 0.08% |
45,102
-6,894
| -13% | -$603K |
|